• Hydroxychloroquine Sulfate Workflow Guide

  2026-08-24

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible way to investigate autophagy pathway modulation and TLR7/9-dependent immune activation in autoimmune disease research. It is suited to freshly prepared, water-based workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or prolonged storage of solutions.

• 7-Ethyl-10-hydroxycamptothecin Workflow Guide

  2026-08-23

  Build reproducible SN-38 experiments around topoisomerase I poisoning, apoptosis, and S-phase/G2 profiling in metastatic colon cancer models. Extend conventional cytotoxicity assays with the FUBP1–FUSE interaction assay to distinguish canonical DNA damage from transcriptional regulatory effects.

• Omeprazole A2845: Acid Secretion Workflow

  2026-08-22

  Omeprazole (SKU A2845) is a research-grade H+,K+-ATPase inhibitor for controlled gastric acid secretion experiments, antiulcer activity studies, and related assay development. This guide covers dossier-based handling and QC while defining boundaries: it is not intended for diagnostic, clinical, or medical use.

• SIS3: A Mechanistic Probe of TGF-β/SMAD3

  2026-08-22

  SIS3, a selective Smad3 inhibitor, offers a rigorous way to test TGF-β/SMAD3 dependency in cancer and fibrosis research. This article connects SIS3 pharmacology with super-enhancer-driven lung adenocarcinoma biology and translates that insight into practical assay decisions.

• BRD4770: G9a Histone Methyltransferase Inhibitor

  2026-08-21

  BRD4770 is a research-focused G9a histone methyltransferase inhibitor for connecting H3K9 methylation changes with senescence and cancer-cell growth phenotypes. This workflow-oriented guide covers formulation challenges, PANC-1 assays, mechanistic controls, and how to interpret findings alongside BRD4–RAC1 pathway research.

• Polybrene: From Transduction Aid to Translational Tool

  2026-08-20

  Polybrene (Hexadimethrine Bromide) is more than a viral delivery additive: it is a controllable experimental variable that can influence attachment, uptake, transfection performance, and assay interpretation. This thought-leadership perspective connects its delivery mechanism with recent findings on mitochondrial proteostasis and outlines a disciplined path from improved transduction to translationally credible conclusions.

• DCPS Links m7G Regulation to Diabetic Foot Ulcer Repair

  2026-08-20

  Xiao et al. identify the decapping scavenger enzyme DCPS as an m7G-related biomarker associated with diabetic foot ulcer pathology and epithelial repair. Integrating transcriptomic analysis with keratinocyte experiments, the study links reduced DCPS to impaired cell-cycle progression, proliferation, migration, and increased apoptosis, while also highlighting limitations that should be addressed before clinical translation.

• Jiao-tai-wan, Coptisine, and SIRT1 in PCOS

  2026-08-19

  A 2025 Phytomedicine study identifies mitochondrial cholesterol import as a mechanistic link between SIRT1 regulation and abnormal ovarian steroidogenesis in a DHEA-induced PCOS model. Its evidence suggests that Jiao-tai-wan and coptisine act partly by limiting SMURF2-mediated SIRT1 degradation, thereby altering StAR localization and theca-cell steroidogenic activity.

• Pol II Degradation and Transcription-Independent Cell Death

  2026-08-19

  The preprint argues that degradation of RNA polymerase II (Pol II) can activate cell death through a mechanism that is not simply a consequence of transcriptional collapse. Its main contribution is conceptual and experimental: it separates the effects of losing Pol II protein from the effects of losing transcription, providing a framework for interpreting regulated cell-death phenotypes after transcriptional perturbation.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-18

  Oliveira and colleagues showed that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects in the spike–AXL interaction. The structure–activity findings extend renin-angiotensin system research into viral receptor biology while emphasizing that antibody-based binding results require validation in cellular and physiological models.

• P2RX1 and Mitochondrial Apoptosis in Ph+ ALL

  2026-08-18

  Li et al. identify P2RX1 as a mechanistic link between calcium dysregulation, CaMKII activation, PI3K/Akt suppression, and mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. The findings suggest that P2RX1 may influence both disease behavior and tyrosine kinase inhibitor response, while also defining experimentally testable readouts for cell-death studies.

• Capsaicin Workflows for TRPV1 and KDM1A Research

  2026-08-17

  Capsaicin enables a two-track research strategy: controlled TRPV1 ion channel activation in sensory models and mechanistic KDM1A/LSD1 inhibition in cancer studies. This workflow connects dose selection, electrophysiology, cell phenotyping, and troubleshooting while separating target-specific effects from solvent, desensitization, and cytotoxicity artifacts.

• Olsalazine Sodium Experimental Workflows

  2026-08-17

  Olsalazine Sodium supports complementary workflows spanning LTB4-driven inflammation, colorectal cancer tumor models, and xenobiotic transport assays. This guide emphasizes aqueous formulation, paired molecular and functional readouts, and troubleshooting strategies that prevent solubility or interpretation errors.

• Anlotinib Hydrochloride Angiogenesis Workflows

  2026-08-16

  Build more informative angiogenesis experiments with Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor that connects endothelial migration, tube formation, receptor phosphorylation, and ERK readouts. This workflow emphasizes dose selection, orthogonal validation, and troubleshooting so anti-angiogenic effects can be separated from nonspecific cytotoxicity.

• Gramine Workflow for TNBC Ferroptosis Research

  2026-08-15

  Gramine is a practical chemical probe for connecting TNBC growth inhibition with ferroptosis, MTDH regulation, and CUL3-dependent ubiquitination. This workflow combines dose-response screening, orthogonal ferroptosis assays, target-engagement tests, and mechanistic rescue experiments for more reproducible cancer biology research.

7978 records 1/532 page Next 12345 下5页 Last page